封面
市場調查報告書
商品編碼
1459808

血型分型市場(產品:儀器、耗材和服務;技術:基於 PCR、基於微陣列、基於測定和大規模並行)- 全球產業分析、規模、佔有率、成長、趨勢和預測, 2023-2031

Blood Group Typing Market (Product: Instruments, Consumables, and Services; and Technique: PCR-based, Microarray-based, and Assay-based, and Massively Parallel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日期: | 出版商: Transparency Market Research | 英文 234 Pages | 商品交期: 2-10個工作天內

價格

血型鑑定市場 - 報告範圍

TMR 關於全球血型定型市場的報告研究了過去以及當前的成長趨勢和機會,以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球血型定型的收入2017-2031年期間的市場,考慮2023年為基準年,2031年為預測年。報告中也提供了2023年至2031年全球血型分型市場的年複合成長率(CAGR %)。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作,其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件,以了解血型分型市場。

市場概況
2022年市場價​​值 26 億美元
2031 年市場價值 55 億美元
CAGR 8.8%

該報告深入探討了全球血型分型市場的競爭格局。全球血型分型市場的主要參與者已被確定,並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、近期發展和 SWOT 是本報告中介紹的全球血型分型市場參與者的屬性。

目錄

第1章:前言

第 2 章:假設與研究方法

第 3 章:執行摘要:全球市場

第 4 章:市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章:關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章:全球市場分析與預測:依產品分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測:按產品,2017-2031
    • 儀器
      • 自動化
      • 半自動化
      • 手動的
    • 耗材
      • 試劑
      • 測試套件
      • 抗血清
      • 其他
    • 服務
  • 市場吸引力:依產品分類

第 7 章:全球市場分析與預測:依技術分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測:依技術分類,2017-2031
    • 基於PCR的
    • 基於微陣列
    • 基於檢測的
    • 大規模平行
    • 7.4 市場吸引力:依技術分類

第 8 章:全球市場分析與預測:通過測試

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測:經測試,2017-2031
    • 抗體篩選
    • HLA分型
    • ABO 血型匹配測試
    • 交叉配血試驗
    • 抗原分型
  • 市場吸引力:經測試

第 9 章:全球市場分析與預測:按最終用戶

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測:按最終用戶,2017-2031
    • 醫院
    • 臨床實驗室
    • 血庫
    • 其他
  • 市場吸引力:按最終用戶分類

第 10 章:全球市場分析與預測:按地區

  • 主要發現
  • 市場價值預測:按地區,2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力:按地區

第 11 章:北美市場分析與預測

第 12 章:歐洲市場分析與預測

第 13 章:亞太市場分析與預測

第 14 章:拉丁美洲市場分析與預測

第 15 章:中東和非洲市場分析與預測

第16章:競爭格局

  • 市場參與者 - 競爭矩陣(依公司層級和規模)
  • 市佔率分析:依公司分類(2022 年)
  • 公司簡介
    • Grifols, SA
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Ortho Clinical Diagnostics
    • AliveDx
    • ABG Health Care GmbH
    • Immucor, Inc.
    • Danaher Corporation
    • Agena Bioscience, Inc.
    • Rapid Labs Ltd.
    • Novacyt Group
Product Code: TMRGL32999

Blood Group Typing Market - Scope of Report

TMR's report on the global blood group typing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global blood group typing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood group typing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the blood group typing market.

Market Snapshot
Market Value in 2022US$ 2.6 Bn
Market Value in 2031US$ 5.5 Bn
CAGR8.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood group typing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood group typing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood group typing market.

The report delves into the competitive landscape of the global blood group typing market. Key players operating in the global blood group typing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood group typing market profiled in this report.

Key Questions Answered in Global blood group typing Market Report:

  • What is the sales/revenue generated by blood group typing across all regions during the forecast period?
  • What are the opportunities in the global blood group typing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Blood Group Typing Market - Research Objectives and Research Approach

The comprehensive report on the global blood group typing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood group typing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood group typing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Group Typing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Blood Group Typing Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Blood Group Typing Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Instruments
      • 6.3.1.1. Automated
      • 6.3.1.2. Semi-automated
      • 6.3.1.3. Manual
    • 6.3.2. Consumables
      • 6.3.2.1. Reagents
      • 6.3.2.2. Test Kits
      • 6.3.2.3. Antisera
      • 6.3.2.4. Others
    • 6.3.3. Services
  • 6.4. Market Attractiveness, by Product

7. Global Blood Group Typing Market Analysis and Forecast, by Technique

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017-2031
    • 7.3.1. PCR-based
    • 7.3.2. Microarray-based
    • 7.3.3. Assay-based
    • 7.3.4. Massively Parallel
    • 7.3.5. 7.4 Market Attractiveness, by Technique

8. Global Blood Group Typing Market Analysis and Forecast, by Test

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Test, 2017-2031
    • 8.3.1. Antibody Screening
    • 8.3.2. HLA Typing
    • 8.3.3. ABO Matching Test
    • 8.3.4. Cross Matching Test
    • 8.3.5. Antigen Typing
  • 8.4. Market Attractiveness, by Test

9. Global Blood Group Typing Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Clinical Laboratories
    • 9.3.3. Blood Banks
    • 9.3.4. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Blood Group Typing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Blood Group Typing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Instruments
      • 11.2.1.1. Automated
      • 11.2.1.2. Semi-automated
      • 11.2.1.3. Manual
    • 11.2.2. Consumables
      • 11.2.2.1. Reagents
      • 11.2.2.2. Test Kits
      • 11.2.2.3. Antisera
      • 11.2.2.4. Others
    • 11.2.3. Services
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Technique, 2017-2031
    • 11.4.1. PCR-based
    • 11.4.2. Microarray-based
    • 11.4.3. Assay-based
    • 11.4.4. Massively Parallel
  • 11.5. Market Attractiveness, by Technique
  • 11.6. Market Value Forecast, by Test, 2017-2031
    • 11.6.1. Antibody Screening
    • 11.6.2. HLA Typing
    • 11.6.3. ABO Matching Test
    • 11.6.4. Cross Matching Test
    • 11.6.5. Antigen Typing
  • 11.7. Market Attractiveness, by Test
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Hospitals
    • 11.8.2. Clinical Laboratories
    • 11.8.3. Blood Banks
    • 11.8.4. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Technique
    • 11.11.3. By Test
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Blood Group Typing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Instruments
      • 12.2.1.1. Automated
      • 12.2.1.2. Semi-automated
      • 12.2.1.3. Manual
    • 12.2.2. Consumables
      • 12.2.2.1. Reagents
      • 12.2.2.2. Test Kits
      • 12.2.2.3. Antisera
      • 12.2.2.4. Others
    • 12.2.3. Services
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technique, 2017-2031
    • 12.4.1. PCR-based
    • 12.4.2. Microarray-based
    • 12.4.3. Assay-based
    • 12.4.4. Massively Parallel
  • 12.5. Market Attractiveness, by Technique
  • 12.6. Market Value Forecast, by Test, 2017-2031
    • 12.6.1. Antibody Screening
    • 12.6.2. HLA Typing
    • 12.6.3. ABO Matching Test
    • 12.6.4. Cross Matching Test
    • 12.6.5. Antigen Typing
  • 12.7. Market Attractiveness, by Test
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Hospitals
    • 12.8.2. Clinical Laboratories
    • 12.8.3. Blood Banks
    • 12.8.4. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Technique
    • 12.11.3. By Test
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Blood Group Typing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Instruments
      • 13.2.1.1. Automated
      • 13.2.1.2. Semi-automated
      • 13.2.1.3. Manual
    • 13.2.2. Consumables
      • 13.2.2.1. Reagents
      • 13.2.2.2. Test Kits
      • 13.2.2.3. Antisera
      • 13.2.2.4. Others
    • 13.2.3. Services
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technique, 2017-2031
    • 13.4.1. PCR-based
    • 13.4.2. Microarray-based
    • 13.4.3. Assay-based
    • 13.4.4. Massively Parallel
  • 13.5. Market Attractiveness, by Technique
  • 13.6. Market Value Forecast, by Test, 2017-2031
    • 13.6.1. Antibody Screening
    • 13.6.2. HLA Typing
    • 13.6.3. ABO Matching Test
    • 13.6.4. Cross Matching Test
    • 13.6.5. Antigen Typing
  • 13.7. Market Attractiveness, by Test
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Hospitals
    • 13.8.2. Clinical Laboratories
    • 13.8.3. Blood Banks
    • 13.8.4. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Technique
    • 13.11.3. By Test
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Blood Group Typing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Instruments
      • 14.2.1.1. Automated
      • 14.2.1.2. Semi-automated
      • 14.2.1.3. Manual
    • 14.2.2. Consumables
      • 14.2.2.1. Reagents
      • 14.2.2.2. Test Kits
      • 14.2.2.3. Antisera
      • 14.2.2.4. Others
    • 14.2.3. Services
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technique, 2017-2031
    • 14.4.1. PCR-based
    • 14.4.2. Microarray-based
    • 14.4.3. Assay-based
    • 14.4.4. Massively Parallel
  • 14.5. Market Attractiveness, by Technique
  • 14.6. Market Value Forecast, by Test, 2017-2031
    • 14.6.1. Antibody Screening
    • 14.6.2. HLA Typing
    • 14.6.3. ABO Matching Test
    • 14.6.4. Cross Matching Test
    • 14.6.5. Antigen Typing
  • 14.7. Market Attractiveness, by Test
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Hospitals
    • 14.8.2. Clinical Laboratories
    • 14.8.3. Blood Banks
    • 14.8.4. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Technique
    • 14.11.3. By Test
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Blood Group Typing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Instruments
      • 15.2.1.1. Automated
      • 15.2.1.2. Semi-automated
      • 15.2.1.3. Manual
    • 15.2.2. Consumables
      • 15.2.2.1. Reagents
      • 15.2.2.2. Test Kits
      • 15.2.2.3. Antisera
      • 15.2.2.4. Others
    • 15.2.3. Services
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Technique, 2017-2031
    • 15.4.1. PCR-based
    • 15.4.2. Microarray-based
    • 15.4.3. Assay-based
    • 15.4.4. Massively Parallel
  • 15.5. Market Attractiveness, by Technique
  • 15.6. Market Value Forecast, by Test, 2017-2031
    • 15.6.1. Antibody Screening
    • 15.6.2. HLA Typing
    • 15.6.3. ABO Matching Test
    • 15.6.4. Cross Matching Test
    • 15.6.5. Antigen Typing
  • 15.7. Market Attractiveness, by Test
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Hospitals
    • 15.8.2. Clinical Laboratories
    • 15.8.3. Blood Banks
    • 15.8.4. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Technique
    • 15.11.3. By Test
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Grifols, S.A.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Bio-Rad Laboratories, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Merck KGaA
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Ortho Clinical Diagnostics
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. AliveDx
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. ABG Health Care GmbH
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Immucor, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Danaher Corporation
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Agena Bioscience, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Rapid Labs Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Novacyt Group
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 03: Global Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 05: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 09: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 10: North America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 14: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 15: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 19: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 20: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 24: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 25: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 29: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 30: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Blood Group Typing Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Blood Group Typing Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Blood Group Typing Market Value Share, by Product, 2022
  • Figure 04: Global Blood Group Typing Market Revenue (US$ Mn), by Technique, 2022
  • Figure 05: Global Blood Group Typing Market Value Share, by Technique, 2022
  • Figure 06: Global Blood Group Typing Market Revenue (US$ Mn), by Test, 2022
  • Figure 07: Global Blood Group Typing Market Value Share, by Test, 2022
  • Figure 08: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global Blood Group Typing Market Value Share, by End-user, 2022
  • Figure 10: Global Blood Group Typing Market Value Share, by Region, 2022
  • Figure 11: Global Blood Group Typing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 13: Global Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 14: Global Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 15: Global Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 16: Global Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 17: Global Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 18: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global Blood Group Typing Market Value Share, by End-user, 2022
  • Figure 20: Global Blood Group Typing Market Value Share Analysis, by Region, 2022-2031
  • Figure 21: Global Blood Group Typing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Blood Group Typing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Blood Group Typing Market Value Share Analysis, by Country, 2022-2031
  • Figure 25: North America Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 26: North America Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 27: North America Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 28: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 29: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 30: North America Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 31: North America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 32: North America Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 33: North America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Europe Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 35: Europe Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 36: Europe Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 37: Europe Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 38: Europe Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 39: Europe Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 40: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 41: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Europe Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 43: Europe Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 44: Europe Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 45: Europe Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 46: Asia Pacific Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 47: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 48: Asia Pacific Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 50: Asia Pacific Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 51: Asia Pacific Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 52: Asia Pacific Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 53: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 54: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 55: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 56: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 57: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 68: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 59: Latin America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 60: Latin America Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Latin America Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 62: Latin America Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 63: Latin America Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 64: Latin America Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 65: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 66: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 67: Latin America Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 68: Latin America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 69: Latin America Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 70: Latin America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 71: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 72: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 73: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 74: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 75: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 76: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 77: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 78: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 79: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 80: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 81: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 82: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031